Rubicon Research Limited is a specialty pharmaceutical company focused on developing complex generic and differentiated formulations. With over two decades of experience in research and development, the company has built a strong presence in regulated markets including the US, Europe, and Latin America. Its IPO has attracted widespread investor attention given the company’s strong fundamentals and sector outlook.
IPO Name, Price Band and Lot Size
The issue is titled the Rubicon Research Limited IPO. The price band was fixed at ₹461–₹485 per share. The lot size was 30 shares, requiring a minimum investment of ₹14,550 at the upper band for retail investors. The IPO comprised a combination of a fresh issue and an offer-for-sale (OFS), allowing existing shareholders to partially offload their stakes while raising growth capital.
IPO Date & Subscription Status
The Rubicon IPO opened for subscription on October 9, 2025, and closed on October 13, 2025. The issue received an overwhelming response from investors. On the final day, the IPO was subscribed over 103 times overall — led by strong demand from Qualified Institutional Buyers (QIBs), followed by Non-Institutional Investors (NIIs) and retail participants. The robust response indicates high confidence in Rubicon’s business model and growth trajectory.
Grey Market Premium (GMP)
The Rubicon IPO GMP (Grey Market Premium) has been trending positively since the issue opened. As per market observers, the rubicon research ltd ipo gmp hovered around ₹95–₹110 before the listing, suggesting a potential 18–22% listing gain over the issue price. While GMP gives an early sentiment indicator, it is an unofficial market and should be viewed cautiously as it may fluctuate before listing.
Corporate Events and Listing Schedule
Post-subscription, the IPO followed a standard timeline for allotment and listing. The basis of allotment was expected to be finalized on October 14, 2025, refunds initiated by October 15, and shares credited to investors’ demat accounts by October 16. The listing date for the Rubicon Research IPO is scheduled for October 17, 2025 on both the NSE and BSE. Investors are optimistic that the strong demand and positive GMP could lead to a premium listing.
Dividend & Bonus
Since Rubicon Research is a newly listed company, there is currently no dividend or bonus record. However, given its healthy profitability and R&D-led growth model, the company may consider future dividends once consistent earnings are established. Investors should watch quarterly results for updates on dividend declarations or any corporate reward plans.
Stock Price & Multibagger Potential
Based on the upper issue price of ₹485 and the prevailing GMP, analysts expect a listing price near ₹580–₹600 per share. However, the long-term performance will depend on the company’s financial growth, regulatory approvals, and pipeline execution. While it operates in a high-potential sector, calling it a multibagger at this early stage would be premature. Investors should evaluate fundamentals, not just short-term premiums.
Steps to Check IPO Allotment Status
- Visit the official registrar website such as Link Intime or KFin Technologies.
- Select “Rubicon Research Limited IPO” from the dropdown menu.
- Enter your PAN or application number.
- Click “Search” to view your allotment status.
- If allotted, check your demat account to confirm share credit before the listing date.
Disclaimer
This content is for informational purposes only and should not be treated as financial advice. IPO investments are subject to market risks. Investors should consult with certified financial advisors before making any investment decisions related to the Rubicon Research IPO or any other securities.
FAQs
Q: What is the Rubicon Research IPO price band and lot size?
A: The price band is ₹461–₹485 per share and the lot size is 30 shares (minimum investment ₹14,550 for retail investors).
Q: What is the Rubicon Research IPO GMP today?
A: The latest GMP for Rubicon Research IPO is in the range of ₹95–₹110, indicating a possible 18–22% premium over the issue price at listing.
Q: When is the Rubicon Research IPO listing date?
A: The listing date is set for October 17, 2025 on the NSE and BSE exchanges.
Q: How can investors check the IPO allotment status?
A: Investors can visit the registrar’s website (Link Intime or KFin Technologies) and check allotment by entering PAN or application number.
